Across TCGA pan-cancer cohorts, LINC01743 RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of LINC01743’s most consistent transcriptional readouts.
The strongest signal is observed in stomach adenocarcinoma (STAD), where LINC01743 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC01743 is over-expressed in tumor.
STAD are the cancer types where LINC01743 tumor–normal differential expression is most reproducible.